CSF-1 released from glioma cells functions as a chemo-attractant, and CSF-1R antagonist reduced the infiltration of TAMs and ameliorated glioblastoma invasion in vivo (54, 55). This evidence concerns the gene CSF1R and central nervous system cancer.